Edan Instruments Inc - Asset Resilience Ratio
Edan Instruments Inc (300206) has an Asset Resilience Ratio of 12.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Edan Instruments Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2021)
This chart shows how Edan Instruments Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Edan Instruments Inc total assets.
Liquid Assets Composition Over Time
This chart breaks down Edan Instruments Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Edan Instruments Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥300.95 Million | 12.01% |
| Total Liquid Assets | CN¥300.95 Million | 12.01% |
Asset Resilience Insights
- Moderate Liquidity: Edan Instruments Inc has 12.01% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Edan Instruments Inc Industry Peers by Asset Resilience Ratio
Compare Edan Instruments Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Edan Instruments Inc (2014–2021)
The table below shows the annual Asset Resilience Ratio data for Edan Instruments Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 4.92% | CN¥100.82 Million ≈ $14.75 Million |
CN¥2.05 Billion ≈ $299.70 Million |
-8.42pp |
| 2020-12-31 | 13.34% | CN¥301.41 Million ≈ $44.11 Million |
CN¥2.26 Billion ≈ $330.57 Million |
+3.26pp |
| 2019-12-31 | 10.08% | CN¥150.96 Million ≈ $22.09 Million |
CN¥1.50 Billion ≈ $219.06 Million |
+9.05pp |
| 2018-12-31 | 1.04% | CN¥14.94 Million ≈ $2.19 Million |
CN¥1.44 Billion ≈ $210.95 Million |
-7.70pp |
| 2017-12-31 | 8.73% | CN¥124.61 Million ≈ $18.23 Million |
CN¥1.43 Billion ≈ $208.83 Million |
+2.17pp |
| 2016-12-31 | 6.56% | CN¥96.25 Million ≈ $14.08 Million |
CN¥1.47 Billion ≈ $214.73 Million |
-13.83pp |
| 2015-12-31 | 20.39% | CN¥296.19 Million ≈ $43.34 Million |
CN¥1.45 Billion ≈ $212.55 Million |
+14.67pp |
| 2014-12-31 | 5.73% | CN¥77.59 Million ≈ $11.35 Million |
CN¥1.36 Billion ≈ $198.29 Million |
-- |
About Edan Instruments Inc
Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and te… Read more